GAMMA Investing’s Aquestive Therapeutics AQST Stock Holding History

GAMMA Investing’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.14K	Buy	463 +164	+55%	+$729	﹤0.01%	3936
2026 Q2	$1.24K	Hold	299	–	–	﹤0.01%	3826
2026 Q1	$1.24K	Buy	299 +107	+56%	+$434	﹤0.01%	3790
2025 Q4	$1.24K	Buy	+192	New	+$1.2K	﹤0.01%	3730

Other funds holding AQST

ACA

Adirondack Capital Advisors Syracuse, New York $194M AUM 14.02% 1-Year Est. Return

CCM

Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's AQST Position: Q3 2026 in Review

GAMMA Investing increased its Aquestive Therapeutics (AQST) stake by 55% in Q3 2026, buying an estimated $729 and bringing the position to 463 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #3936.

GAMMA Investing first reported a position in AQST in Q4 2025 and has held it in 4 quarters since. 5 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

GAMMA Investing held 463 shares of Aquestive Therapeutics worth $2.14K as of Q3 2026.
GAMMA Investing bought 164 Aquestive Therapeutics shares in Q3 2026, an estimated $729.
Aquestive Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3936 holding.
GAMMA Investing first reported a position in Aquestive Therapeutics in Q4 2025 and has held it in 4 quarters since.
5 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.